The World Health Organisation, on Friday, said Africans were at higher risk of dying of viral hepatitis than dying of AIDS, malaria and tuberculosis.
This was made known in a statement from its Africa office, in which the scorecard for hepatitis prevalence in Africa was released.
WHO said, “A new scorecard, the first to examine hepatitis prevalence and response in the World Health Organization African region, shows that only three of the 47 countries are on track to eliminate the disease that affects one in 15 people in the region.
“Dying of viral hepatitis in Africa is becoming a bigger threat than dying of AIDS, malaria or tuberculosis.”
Dr Matshidiso Moeti, WHO Regional Director for Africa said, “This analysis is the first to track each country in the region and to assess progress towards the goal of saving the lives of more than two million Africans who may develop progressive hepatitis B or C liver disease in the next decade if countries fail to ramp up their efforts.”
Part of the statement also revealed that the scorecard,”provides vital information about the status of the regional hepatitis response, measuring progress against the Framework for Action for the Prevention, Care and Treatment of Viral Hepatitis in the African Region (2016–2020).
It was created as a guide for Member States on the implementation of the Global Health Sector Strategy on Viral Hepatitis, which calls for the elimination of hepatitis by 2030 (defined as a 90% reduction in new cases and 65% reduction in deaths).
“The analysis shows that 28 countries have developed a national hepatitis strategic plan for viral hepatitis; however, most are still in draft form with only 13 officially published and disseminated.
“Only 15% (7/47) countries are leading prevention efforts with national coverage of both Hepatitis B birth dose and childhood pentavalent vaccination exceeding 90%. There are major gaps in hepatitis testing and treatment with less than eight countries providing subsidized testing and treatment for viral hepatitis. Uganda has started free nationwide hepatitis B treatment, and Rwanda is providing free treatment for both hepatitis B and C.
“Every year more than 200 000 people in Africa are dying from complications of viral hepatitis B and C-related liver disease, including cirrhosis and liver cancer. Sixty million people in the WHO Africa Region were living with chronic hepatitis B infection in 2015. More than 4.8 million of them are children under five years old. A further 10 million are infected with hepatitis C, most likely due to unsafe injection practices within health facilities or by communities.”
The scorecard will be presented at the first African Hepatitis Summit to be held in Kampala, Uganda.